Mode
Text Size
Log in / Sign up

Meta-analysis finds 23% subthreshold depression prevalence in patients with diabetes mellitus

Meta-analysis finds 23% subthreshold depression prevalence in patients with diabetes mellitus
Photo by Victoria Volkova / Unsplash
Key Takeaway
Note that subthreshold depression is common in diabetes, particularly in developing countries and hospital settings.

This systematic review and meta-analysis examined the prevalence of subthreshold depression in patients with diabetes mellitus. It included 33 cross-sectional and cohort studies from developing countries, hospitals, and other settings, totaling 255,371 participants. The analysis focused on the prevalence of subthreshold depression as the primary outcome, with secondary comparisons across countries, gender, settings, and study designs.

The pooled prevalence of subthreshold depression across all studies was 23.0% (95% CI: 20.0%-26.0%), with substantial heterogeneity (I² = 99.2%, p < 0.001). Subgroup analyses showed higher prevalence in developing countries (26.6%), females (16.0%), cross-sectional studies (24.5%), and patients in hospital settings (24.5%). No safety or tolerability data were reported, as this was a prevalence study rather than an intervention trial.

Key limitations include the observational nature of the included studies, which precludes causal inference, and the high statistical heterogeneity (I² = 99.2%), indicating substantial variation between studies that the analysis could not fully explain. The funding sources and potential conflicts of interest were not reported.

For practice, these findings highlight that subthreshold depression is frequently observed in diabetes populations, particularly in resource-limited settings and hospital environments. The authors suggest enhanced screening and interventions should target high-risk groups, emphasizing the importance of addressing mental health in diabetes management. However, clinicians should interpret these prevalence estimates cautiously due to the heterogeneity and observational design of the underlying evidence.

Study Details

Study typeMeta analysis
Sample sizen = 371
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
AIMS: Subthreshold depression has low clinical recognition, but increases patients' risk of complications and impairs their quality of life. This study aimed to systematically review the literature to determine the prevalence of subthreshold depression in patients with diabetes mellitus and compare rates across countries, gender, settings and study designs. DESIGN: This was a systematic review and meta-analysis of cross-sectional and cohort studies. METHODS: We searched nine databases (PubMed, PsyclNFO, CINAHL, The Cochrane Library, EMbase, Web of Science, China Knowledge Resource Integrated Database (CNKI), Chinese Biomedical Database (CBM) and Wanfang) to 15 February 2026. Meta-analysis was performed using the Stata 16.0 software package, and the prevalence of each study report was combined based on a random-effect model. Subgroup analyses were performed. RESULTS: In total 2564 articles were retrieved, of which 33 met the inclusion criteria for meta-analysis, involving 255 371 participants. The pooled prevalence of subthreshold depression in patients with diabetes mellitus was 23.0% (95% CI: 20.0%-26.0%, I = 99.2%, p < 0.001). Subgroup analyses revealed higher prevalence in developing countries (26.6%), females (16.0%), cross-sectional studies (24.5%) and patients in hospital (24.5%). CONCLUSIONS: The findings highlight overall high rates but also substantial disparities in the prevalence of subthreshold depression in patients with diabetes mellitus across demographics and settings, with elevated rates in developing nations and female patients. Findings suggest enhanced screening and interventions should target high-risk groups and underscore the importance of addressing mental health in diabetes management, particularly in resource-limited settings and among vulnerable populations. Review Registration PROSPERO: CRD42024615241.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.